Mise à jour du trading semestriel
Millimages
€25.52
16:30 01/09/22
Pour diffusion immédiate | 4 Avril 2024 |
Gooch & Housego SA
("G&H" ou la "Société" ou le "Groupe")
Mise à jour du trading semestriel
"Trading in line with management's expectations"
Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components and systems, provides an update on trading for the six months ended 31 March 2024.
Commerce
As previously reported, in the first half of the financial year the Group has seen some customers in its industrial and medical laser markets normalise their inventory holdings resulting in lower levels of demand for some of the Group's products. This period of destocking is expected to come to an end towards the end of this calendar year and the Group's revenue from these end markets will then return to growth. In other parts of the Group, most notably our medical diagnostic business and our fibre optic businesses, which supply the semiconductor infrastructure markets, revenue has grown compared with the comparator period.
Revenue for the six month period is expected to be circa £67.5 million (31 March 2023: £71.3 million) supported by the two acquisitions completed in the previous financial year. As previously reported, we expect trading in the current financial year to be more heavily weighted towards the second half than in FY2023.
New orders for the Group's products from our semiconductor, sub-sea data cable and aerospace navigation markets have been strong. We have secured an important new customer for a new fibre optic amplifier module as well as strong orders for our medical diagnostic products. Requests for quotations for our optical systems solutions for armoured vehicles are strong and we expect to convert a number of these into firm orders in the second half of the year.
At 31 March 2024 the Group's order book stood at £115.8 million (31 March 2023: £124.4 million), a decrease of 6.9%, but an increase of 3.6% on an organic constant currency basis, compared with the same time last year. The order book has grown by 2.3% compared with its level at 30 September 2023 on an organic, constant currency basis This order book provides good coverage for our expected second half revenues.
We remain in a strong financial position with a robust balance sheet and significant levels of available funding to support the Group's further growth. At the half year net debt was circa £32 million (March 2023: £19.2 million and September 2023: £31.7 million) and the Group had $35.7 million available from existing committed and uncommitted debt facilities to fund its future growth activities.
We expect trading for the full year to be in line with management's previous expectations.
Progrès stratégique
The Group is making good progress in delivering the strategic plan announced last year. The divestment of our EM4 business completed in March 2024 allows the Group to focus its resources on those parts of its A&D portfolio where it can differentiate itself and achieve acceptable returns.
The transfer of carefully selected product lines to contract manufacturing partners in lower cost regions is accelerating. Fused fibre couplers are now being produced in volume by two outsourced partners and the share of the Group's volumes for this product line being outsourced will now increase with further product lines identified to be transferred.
The Group's new medical diagnostic design, development and production facility based in our Rochester site has been opened. We were pleased to be joined by one of our significant life science customers for the official opening ceremony as this new facility will be serving their North American market requirements. We expect further material orders for our expanded US Life Sciences centre of excellence in the second half of this financial year.
The Group will announce its interim results for the six months ended 31 March 2024 on 4 June 2024.
Charlie Peppiatt, PDG de Gooch & Housego, a commenté :
"Despite the lower volumes in the first half of the financial year resulting from a prolonged period of inventory adjustment by some of our customers we have continued to focus on the delivery of our strategic objectives. In line with our commitment to become a more customer focused business, we have further improved our operational performance reducing our overdue backlog and lead times.
"Our investment in new technologies and products is recognised by our customers and we have secured important new contract wins in the period. Following the strategic addition of the GS Optics and Artemis Optical businesses in FY2023, we have already been rewarded with new customer orders as a result of the Group's enhanced portfolio.
"The divestment of our EM4 business in March this year represented an important milestone on our journey to focus our A&D business on those areas where we can secure acceptable returns, supporting the Group's path to mid-teens profitability."
Pour de plus amples informations s'il vous plaît contacter:
Charlie Peppiatt, directeur général Chris Jewell, directeur financier | Gooch & Housego SA | +44 (0) 1460 256440 |
| ||
Mark Court/Sophie Wills/Abigail Gilchrist | Buchanan | + 44 (0) 20 7466 5000 |
| ||
Christopher Baird/David Anderson | Investec Banque plc | + 44 (0) 20 7597 5970 |
Notes aux rédacteurs
1. Gooch & Housego est une entreprise de technologie photonique basée à Ilminster, Somerset, Royaume-Uni, avec des opérations aux États-Unis et en Europe. Leader mondial dans son domaine, la société recherche, conçoit, développe et fabrique des systèmes photoniques avancés, des composants et de l'instrumentation pour des applications dans les secteurs de l'aérospatiale et de la défense, de l'industrie, des sciences de la vie et de la recherche scientifique. Une expertise de pointe en matière de conception, de développement et de fabrication est offerte dans une large gamme de technologies complémentaires.
2. Toutes les informations financières incluses dans cette annonce proviennent de comptes de gestion non audités et excluent tout élément spécifique. Cette annonce contient certaines déclarations prospectives fondées sur les attentes ou croyances actuelles de la direction ainsi que sur des hypothèses concernant des événements futurs. Celles-ci sont soumises à des facteurs de risque associés, entre autres, aux circonstances économiques et commerciales survenant de temps à autre dans les pays et les secteurs dans lesquels G&H opère. On pense que les attentes reflétées dans ces déclarations sont raisonnables, mais elles peuvent être affectées par un large éventail de variables qui pourraient faire en sorte que les résultats réels, ainsi que les plans et objectifs de G&H, diffèrent sensiblement de ceux actuellement anticipés ou implicites dans les déclarations prospectives. . Les investisseurs ne doivent pas se fier indûment à ces déclarations. Rien dans cette annonce ne doit être interprété comme une prévision de bénéfice.
RNS peut utiliser votre adresse IP pour confirmer le respect des termes et conditions, pour analyser votre interaction avec les informations contenues dans cette communication et pour partager cette analyse de manière anonyme avec d'autres dans le cadre de nos services commerciaux. Pour plus d'informations sur la manière dont RNS et la Bourse de Londres utilisent les données personnelles que vous nous fournissez, veuillez consulter notre Politique de confidentialité.